Physician profile
Odell Barnwell, III
NPI 1487755757
$2,303.80
in general payments reported to CMS, 2019-2025
25 companies · $434 in 2025
The $434 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $161 · 2021: $91.29 · 2022: $212 · 2023: $360 · 2024: $442 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $500.19 | 2019-2025 | Onyda Xr |
| Corium, LLC | $435.68 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $225.97 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Pfizer INC. | $215.86 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $132.45 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Supernus Pharmaceuticals, INC. | $92.13 | 2021-2024 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $91.20 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $78.37 | 2025 | Jornay Pm |
| Incyte Corporation | $69.70 | 2023-2025 | Opzelura |
| Cognoa, INC. | $63.82 | 2021-2022 | |
| Neos Therapeutics, LP | $61.34 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $47.67 | 2025 | Neffy |
| Cranial Technologies, INC | $39.22 | 2023-2024 | Doc Band |
| Phadia US INC. | $38.90 | 2020-2021 | |
| Seqirus USA INC | $32.31 | 2024-2025 | Flucelvax |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $30.70 | 2019 | |
| Ironwood Pharmaceuticals, INC | $24.98 | 2024 | |
| Organon LLC | $20.83 | 2025 | |
| Mylan Pharmaceuticals INC. | $20.60 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.00 | 2019 | |
| Medline Industries LP | $13.75 | 2024 | |
| Ironshore Pharmaceuticals INC. | $13.67 | 2019 | |
| Mission Pharmacal Company | $12.96 | 2019 | |
| Adlon Therapeutics L.P. | $12.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Odell Barnwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.